Evidence map›Paper›PMID 34423653›Full record

ArticleJournal of the American Heart Association2021

The Intersection of Type 2 Myocardial Infarction and Heart Failure.

Cian P McCarthy, Maeve Jones-O'Connor, David S Olshan, Sean Murphy, Saad Rehman, Joshua A Cohen, Jinghan Cui, Avinainder Singh, Muthiah Vaduganathan, James L Januzzi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Intersection of Type 2 Myocardial Infarction and Heart Failure.Journal of the American Heart Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Cian P McCarthyDivision of Cardiology Department of Medicine Massachusetts General Hospital Boston MA.
Maeve Jones-O'ConnorDepartment of Medicine Massachusetts General Hospital Boston MA.
David S OlshanDepartment of Medicine Massachusetts General Hospital Boston MA.
Sean MurphyDepartment of Medicine Massachusetts General Hospital Boston MA.ORCID 0000-0002-5928-5974
Saad RehmanDepartment of Medicine Massachusetts General Hospital Boston MA.
Joshua A CohenDivision of Cardiology Department of Medicine Cleveland Clinic Cleveland OH.
Jinghan CuiDivision of Cardiology Department of Medicine Massachusetts General Hospital Boston MA.
Avinainder SinghDepartment of Medicine Yale-New Haven Hospital New Haven CT.ORCID 0000-0003-1717-005X
Muthiah VaduganathanBrigham and Women's Hospital Heart & Vascular Center Harvard Medical School Boston MA.ORCID 0000-0003-0885-1953
James L JanuzziDivision of Cardiology Department of Medicine Massachusetts General Hospital Boston MA.ORCID 0000-0002-8338-1798
Jason H WasfyDivision of Cardiology Department of Medicine Massachusetts General Hospital Boston MA.ORCID 0000-0002-0871-5970
Massachusetts General Hospital · USBrigham and Women's Hospital · USCleveland Clinic · USMurphy Oil Corporation (United States) · USYale New Haven Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002541
6 · The paper itself

Abstract

Background Type 2 myocardial infarction (T2MI) is common and associated with high cardiovascular event rates. However, the relationship between T2MI and heart failure (HF) is uncertain. Methods and Results We identified patients with T2MI at a large tertiary hospital between October 2017 and May 2018. Patient characteristics, causes of T2MI, and subsequent HF hospitalizations were determined by physician chart review. We identified 359 patients with T2MI over the study period; 184 patients had a history of HF. Among patients with ejection fraction (EF) assessment (N=180), the majority had preserved EF (N=107; 59.4%), followed by reduced EF (N=54; 30.0%), and mid-range EF (N=19; 10.6%). Acute HF was the most common cause of T2MI (20.9%). Of those whose T2MI was precipitated by HF (N=75), the mean EF was 53.0±16.8% and 16 (21.3%) were de novo diagnoses of HF. Among patients with T2MI who were discharged alive with available follow-up (N=289), 5.5% were hospitalized with acute HF within 30 days, 17.3% within 180 days, and 22.1% within 1 year. In subgroup analyses, among patients with T2MI with prevalent or new HF (N=161), the rate of HF hospitalization at 1 year was 34.2%, considerably higher than those with T2MI and no HF diagnosis at discharge (7.0%; N=9/128). Conclusions Index presentations of HF or worsening chronic HF represent the most common causes of T2MI. ≈1 in 5 patients with T2MI will be readmitted for HF within 1 year of their event. Strategies to prevent HF events after a T2MI are needed.

Indexed as

Anterior Wall Myocardial InfarctionHeart FailureHospitalizationHumansStroke VolumeVentricular Function, Leftheart failureoutcomestype 2 myocardial infarction

Identifiers

PMID34423653
PMCPMC8649278
OpenAlexW3195968699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.